An Observational, Prospective Study to Evaluate the Hemoglobin Levels in Non-dialysis Chronic Kidney Disease Subjects With Renal Anaemia, Treated With MIRCERA (Methoxy-polyethylene-glycol-epoetin Beta) (OPTIMA).

Trial Profile

An Observational, Prospective Study to Evaluate the Hemoglobin Levels in Non-dialysis Chronic Kidney Disease Subjects With Renal Anaemia, Treated With MIRCERA (Methoxy-polyethylene-glycol-epoetin Beta) (OPTIMA).

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2016

At a glance

  • Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Acronyms OPTIMA
  • Sponsors Roche
  • Most Recent Events

    • 01 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 01 Feb 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov record.
    • 01 Jul 2015 Planned End Date changed from 1 Aug 2016 to 1 Oct 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top